Citation Impact
Citing Papers
Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity
2006
The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response
2009 StandoutNobel
Bump-and-Hole Engineering Identifies Specific Substrates of Glycosyltransferases in Living Cells
2020 StandoutNobel
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults
2020
Zanamivir Use During Transmission of Amantadine-Resistant Influenza A in a Nursing Home
2000
Determining cell type abundance and expression from bulk tissues with digital cytometry
2019 Standout
Applications of nanotechnology for immunology
2013
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Influenza-Associated Hospitalizations in the United States
2004 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Effect of Immunosuppression on T-Helper 2 and B-Cell Responses to Influenza Vaccination
2015 StandoutNobel
Antivirals for influenza in healthy adults: systematic review
2006
Chimeric Flaviviruses: Novel Vaccines against Dengue Fever, Tick-borne Encephalitis, and Japanese Encephalitis
2003
Neurovirulence of yellow fever 17DD vaccine virus to rhesus monkeys
2003
Health and Productivity: A Role for Occupational Health Professionals
2001
Current assessment of yellow fever and yellow fever vaccine
2004
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
New developments in flavivirus vaccines with special attention to yellow fever
2005
Use of Oseltamivir During Influenza Outbreaks in Ontario Nursing Homes, 1999–2000
2002
Live Attenuated versus Inactivated Influenza Vaccine in Infants and Young Children
2007 Standout
Strategies for containing an emerging influenza pandemic in Southeast Asia
2005 StandoutNature
Antiviral chemotherapeutic agents against respiratory viruses
2004
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study
2020 Standout
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2001
Biological roles of glycans
2016 Standout
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
2015 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Lost Productive Time and Cost Due to Common Pain Conditions in the US Workforce
2003 Standout
Long‐Term Use of Oseltamivir for the Prophylaxis of Influenza in a Vaccinated Frail Older Population
2001
Transdermal drug delivery
2008 Standout
Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development
2010 StandoutNobel
Microneedle-Based Vaccines
2009
Age-dependent dysregulation of innate immunity
2013
Taking dendritic cells into medicine
2007 StandoutNatureNobel
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Viral vectors for malaria vaccine development
2006
An Outbreak of Influenza A in a Neonatal Intensive Care Unit
2000
Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza
2000
Vaccines for preventing influenza in healthy adults
2010
Innate Immune Function by Toll-like Receptors: Distinct Responses in Newborns and the Elderly
2012
Influenza virus neuraminidase inhibitors
2000
Does Medicare Save Lives?*
2009 StandoutNobel
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
Systems biology of vaccination for seasonal influenza in humans
2011
Genomic characterization and phylogenetic analysis of Zika virus circulating in the Americas
2016
Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses
2004
The Jak-STAT signaling pathway is required but not sufficient for the antiviral response of drosophila
2005 StandoutNobel
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
2018 StandoutNobel
Cost-Benefit Analysis of a Strategy to Vaccinate Healthy Working Adults Against Influenza
2001
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
2003 Standout
Reverse Genetics of Measles Virus and Resulting Multivalent Recombinant Vaccines: Applications of Recombinant Measles Viruses
2008
Guidelines for the management of adult lower respiratory tract infections
2005
Immunogenicity and protective efficacy of a recombinant yellow fever vaccine against the murine malarial parasite Plasmodium yoelii
2010 StandoutNobel
Quantitative Super-Resolution Microscopy of the Mammalian Glycocalyx
2019 StandoutNobel
Adjuvanted influenza vaccines
2012
Guidelines for the Management of Adults with Community-acquired Pneumonia
2001 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Safety and Efficacy of Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine Formulations in Nonhuman Primates
2004
Simultaneous Detection of Influenza Viruses A and B Using Real-Time Quantitative PCR
2001
Immunosenescence and Novel Vaccination Strategies for the Elderly
2013
A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong
2003 Standout
ChimeriVax-West Nile Virus Live-Attenuated Vaccine: Preclinical Evaluation of Safety, Immunogenicity, and Efficacy
2004
Utility of Humanized BLT Mice for Analysis of Dengue Virus Infection and Antiviral Drug Testing
2013 StandoutNobel
Management of Influenza
2000
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
2006 Standout
Advances in the development of influenza virus vaccines
2015
One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
2021 StandoutNobel
Nucleoside-Modified mRNA-Based Influenza Vaccines Circumvent Problems Associated with H3N2 Vaccine Strain Egg Adaptation
2022 StandoutNobel
Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster
2012 StandoutNobel
Improving the evidence base for decision making during a pandemic: the example of 2009 influenza A/H1N1.
2011
Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A
2011 StandoutNobel
Recombinant Yellow Fever Vaccine Virus 17D Expressing Simian Immunodeficiency Virus SIVmac239 Gag Induces SIV-Specific CD8 + T-Cell Responses in Rhesus Macaques
2010
Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans
2011 StandoutNobel
Polymeric Nanostructures for Imaging and Therapy
2015
Oral Oseltamivir in Human Experimental Influenza B Infection
2000
Chaperone-Assisted Protein Folding Is Critical for Yellow Fever Virus NS3/4A Cleavage and Replication
2016 StandoutNobel
Yellow fever vaccine
2005
Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes
2005 StandoutNobel
Yellow fever 17D as a vaccine vector for microbial CTL epitopes
2005 StandoutNobel
Pathogenesis of West Nile Virus Infection: a Balance between Virulence, Innate and Adaptive Immunity, and Viral Evasion
2006
Mimicking live flavivirus immunization with a noninfectious RNA vaccine
2004
Guidelines for Preventing Health-Care-Associated Pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee
2004 Standout
Changing Face of Vaccination in Immunocompromised Hosts
2014
Structural basis for Zika envelope domain III recognition by a germline version of a recurrent neutralizing antibody
2020 StandoutNobel
Vaccines: the Fourth Century
2009
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Challenges of Making Effective Influenza Vaccines
2020
Neuraminidase inhibitors for preventing and treating influenza in healthy adults
2006
Advances in Oral Subunit Vaccine Design
2020
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
2020 Standout
Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
2001 Standout
Works of Casey Johnson being referenced
A live, attenuated recombinant West Nile virus vaccine
2006
Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response
2012
Immunopotentiation of Trivalent Influenza Vaccine When Given with VAX102, a Recombinant Influenza M2e Vaccine Fused to the TLR5 Ligand Flagellin
2010
Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza–flagellin fusion vaccine (VAX125, STF2.HA1 SI)
2011
Use of the Selective Oral Neuraminidase Inhibitor Oseltamivir to Prevent Influenza
1999
Clinical proof of principle for ChimeriVax™: recombinant live, attenuated vaccines against flavivirus infections
2002
Chimeric Live, Attenuated Vaccine against Japanese Encephalitis (ChimeriVax‐JE): Phase 2 Clinical Trials for Safety and Immunogenicity, Effect of Vaccine Dose and Schedule, and Memory Response to Challenge with Inactivated Japanese Encephalitis Antigen
2003
Safety and immunogenicity of a recombinant M2e–flagellin influenza vaccine (STF2.4xM2e) in healthy adults
2011
Safety and immunogenicity of a novel nanoemulsion mucosal adjuvant W805EC combined with approved seasonal influenza antigens
2011
Safety and Immunogenicity of 3 Formulations of an Investigational Respiratory Syncytial Virus Vaccine in Nonpregnant Women: Results From 2 Phase 2 Trials
2018